April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Gene Expression and Epigenomic Profiling of Th17 Cells in Steroid Refractory Uveitis
Author Affiliations & Notes
  • R. W. Lee
    Clinical Science at South Bristol, University of Bristol, Bristol, United Kingdom
    National Eye Inst/NIH, Bethesda, Maryland
  • H. Sen
    National Eye Inst/NIH, Bethesda, Maryland
  • Z. Li
    National Eye Inst/NIH, Bethesda, Maryland
  • L. P. Schewitz-Bowers
    Clinical Science at South Bristol, University of Bristol, Bristol, United Kingdom
  • A. D. Dick
    Clinical Science at South Bristol, University of Bristol, Bristol, United Kingdom
  • R. B. Nussenblatt
    National Eye Inst/NIH, Bethesda, Maryland
  • L. Wei
    National Eye Inst/NIH, Bethesda, Maryland
  • Footnotes
    Commercial Relationships  R.W. Lee, None; H. Sen, None; Z. Li, None; L.P. Schewitz-Bowers, None; A.D. Dick, None; R.B. Nussenblatt, None; L. Wei, None.
  • Footnotes
    Support  National Institute for Health Research (UK), National Eye Research Centre grants RJ4740 and RJ5058
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 2922. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      R. W. Lee, H. Sen, Z. Li, L. P. Schewitz-Bowers, A. D. Dick, R. B. Nussenblatt, L. Wei; Gene Expression and Epigenomic Profiling of Th17 Cells in Steroid Refractory Uveitis. Invest. Ophthalmol. Vis. Sci. 2010;51(13):2922.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Patients with steroid refractory (SR) uveitis have a characteristic subpopulation of SR CD4+ T cells in their peripheral blood. We have previously demonstrated that this SR phenotype is restricted to the central memory pool of CD4+ cells which have the capacity to generate IL-17. We therefore interrogated the transcriptomic and epigenomic responses of Th17 cells to corticosteroids in order to identify novel biomarkers and targets for therapeutic intervention in steroid refractory disease.

Methods: : CD4+CCR6+ and CD4+CCR6- cells isolated from the PBMCs of patients with SR and steroid sensitive (SS) uveitis were cultured for 2 weeks in Th17 versus Th1 polarizing conditions prior to treatment with 10-6M Dexamethasone (Dex). Differences in gene expression were analysed by microarray (Affymetrix). Genome-wide H3K4me3 and H3K27me3 maps were generated by chromatin immunoprecipitation coupled with high-throughput sequencing (ChIP-seq, Illumina).

Results: : IL-17 production was greater in CD4+CCR6+ cells cultured in Th17 conditions from SR patients (49.5% vs 10.6% / SR vs SS). However, principal component analysis demonstrated that once generated, Th17 cells from either SR or SS patients had an equally restricted response to Dex compared to Th1 cells. Key upregulated transcripts in SR Th17 cultures exposed to Dex were FKBP5, CXCL13 and IL7R. Downregulated transcripts included IL22, CD160 and IL23R. Histone modification changes were associated with altered gene expression.

Conclusions: : SR patients have a greater propensity than SS patients to generate Th17 cells, but Th17 cells from either group of patients have a similarly restricted change in gene expression following exposure to Dex compared with Th1 cells. Our transcriptome and epigenome data provide candidate biomarkers for differing steroid responses between patients, and also suggest an epigenetic mechanism underlying steroid refractory diseases.

Keywords: immunomodulation/immunoregulation • corticosteroids • gene microarray 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×